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Multiple testing in big dataIn an era of increasing availability and accessibility of
huge and complex databases resulting from research or rou-
tinely collected sources [1,2], the question on dealing with
or adjusting for multiple statistical testing is even more
challenging than before. The key dilemma is how to detect
meaningful associations on one hand, while avoiding nu-
merous false-positive results at the other. Both conceptual
and technical issues are at stake.
As to the conceptual issues, several questions can be
posed. For example, how should ‘‘multiple testing’’ be de-
fined? Is it a large series of tests being performed in one
specific analysis? Or should one also take all other tests into
account that have been carried out before by previous in-
vestigators in the same database? If the latter is the case,
who or what is registering all the testing that has already
been done in the past and how will this cumulative history
be integrated in new or even future analyses? And, to what
extent is performing a large number of tests based on more
or less defined hypotheses less of a problem that just fish-
ing? Furthermore, should the scientific justification of such
hypotheses be taken into account or even be independently
reviewed before doing the analysis? What would be the im-
plications of record linkage in this context? And how
should this all be transparently reported so as to avoid pub-
lication bias?
Regarding the technical side, the first question still is
whether we should use statistical adjustments for the num-
ber of tests to be performed. Or should we just use a simple
approach of unadjusted testing overall but do additional in-
vestigations and more focused analysis when in explorative
analyses potentially relevant results have come forward?
And if we are to use technical adjustment, what is the
way to go? [3].
These and related questions and problems require inno-
vative thinking and methodology development. In this
issue, Glickman et al. introduce an alternative to
Bonferroni-type adjustments. To optimize error rate control
with procedures that distinguish between hypothesis- and
exploratory and/or data-driven testing, they recommend
the ‘‘false discovery rate control’’. In a review, they explain
this approach and illustrate its advantages using two recent
health studies.
Related to this subject is the assessment of the validity of
large databases. Valkhoff did so by evaluating the accuracy
of disease codes and free text in identifying upper gastroin-
testinal bleeding from four European electronic health0895-4356  2014 Elsevier Inc.
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the effect of outcome misclassification on estimation of
drug-related bleeding. It was concluded that ICD (Interna-
tional Classification of Diseases)-related coding systems
had a good positive predictive value, and that less granular
terminology [4] may require additional strategies. Also
Benchimol et al. studied the validity of health administra-
tive databases, focusing on accurate disease ascertainment
using adult-onset inflammatory bowel disease (IBD) identi-
fication algorithms. Data from two large cohorts of incident
patients were linked to health administrative data, and it
was found that incident IBD could be accurately identified
from within health administrative data.
Compared with large database research, the methodo-
logical quality of clinical intervention studies, especially
as represented in systematic reviews and randomized trials,
is much more crystallized and developed. However, there
are still many opportunities for further improvement in var-
ious phases and types of research.
Systematic reviews and meta-analyses are often consid-
ered to represent the highest level of evidence, but as
Hunter et al. emphasize, they should contain an assessment
of the potential for publication bias to have influenced the
results. These authors studied the utility of funnel plots in
this context, based on a simulation study and a meta-
analysis of published literature on perioperative mortality
after abdominal aortic aneurysm repair. They conclude that
conventional funnel plots are an inaccurate way to assess
publication bias in meta-analyses with low proportion out-
comes and propose an alternative funnel plot.
As to decision making on scientifically and ethically ap-
proving trials, ‘‘equipoise’’ is traditionally an important
concept to be taken into account. Donovan et al. studied
how doctors considered and experienced this concept when
recruiting participants to randomized controlled trials
(RCTs). From the results from in-depth interviews with
doctors involved in six publicly funded trials, they conclude
that recruitment to trials is a difficult and fragile process.
They suggest that training and support can enable most
doctors to become comfortable with important RCT con-
cepts including equipoise and can promote a more resilient
recruitment process.
As the nocebo effect (namely, an ‘‘unpleasant’’ response
to the application of sham treatment and/or by the sugges-
tion of negative expectations) has been less studied than the
placebo effect, Koog et al. investigated the nocebo effect
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no-treatment groups. From their systematic review, the au-
thors suggest that the nocebo effect is clinically meaning-
ful, and that clinicians should not only be interested in
positive effects but also be cautious about negative effects
associated with acupuncture.
Pragmatic trials are attractive when we are looking for
the real-life clinical effects, but they may be subject to po-
tential biases. In this context, Dascanio et al. emphasize the
cohort factorial randomized trial design as an option to re-
duce some of the biases associated with unblinded trials.
They tested the feasibility of this approach for studying
the effect of treatments of low back pain and conclude that
the design should be considered when evaluating novel in-
terventions in chronic musculoskeletal problems.
Even more than pragmatic trials, observational studies
are subject to bias. Because in critical care medicine
randomized trials are often difficult to perform, Zhang
et al. evaluated the effect sizes of experimental treatments
based on propensity score (PS) analysis of observational
studies, in comparison with (meta-analysis of) randomized
trials. Contrary to what is usually seen, they found that ob-
servational research is likely to report less beneficial effects
than RCTs, and they discuss the implications of this
finding.
Intervention effects may differ considerably in sub-
groups, and it is often a challenge to clarify such differen-
ces. Using data from a study of the effects of a weight loss
intervention trial, de Vos c.s. applied latent class growth
analysis (LCGA) to identify distinct subgroups with differ-
ent weight change trajectories. Evaluating the results, the
authors concluded that LCGA was a suitable method for
this purpose.
For the preparation, conduct, and interpretation of re-
search, more insight into what actually happens to people
who participate in studies is very important. Therefore, taking
further their recently published articles in The Journal of
Clinical Epidemiology [5,6], McCambridge et al. highlight
their view on the need for better guidance for empirical inves-
tigations of ‘‘research participation effects’’. They discuss
existing concepts and previous studies on participating in re-
search and suggest that mixed methods participant-centered
research may lead to better prevention of bias.
Good response rates are the basis for good research par-
ticipation, but these are often difficult to achieve and espe-
cially in mental health settings this may not be easy. In this
context, Maclean et al. performed a large factorial random-
ized trial to examine the effect of a prenotification postcard
and a short teaser message on response rates to a mailed
questionnaire on bulimia nervosa ‘‘mental health literacy’’.
It was found that the prenotification postcard-enhanced re-
sponse rates, but the teaser did not.
In clinical epidemiological research, comorbidity in
health outcome is increasingly a central point of interest.
Frei et al. aimed to identify the comorbidities with the
greatest impact on patient-reported health status in chronicobstructive disease and developed a comorbidity index to
reflect their combined impact: the COMCOLD index.
Based on patient data from an international collaborative
chronic obstructive pulmonary disease study, they conclude
that this new index is well suited for its purpose and com-
plements existing comorbidity indices that predict mortal-
ity. Important health events can also be predicted using
probability and decision trees. This was shown by Rafiq
et al. in the context of a large general practice (GP)-based
multicenter trial on quality improvement in chronic kidney
disease in elderly patients. From a range of available candi-
date predictors, a decision tree and risk score were gener-
ated that, once validated, can be used in routine GP falls
assessments. As it is often erroneously assumed that the in-
ternal reliability of instruments is stable across studies, in a
systematic review, Smith c.s. evaluated homogeneity and
determinants of heterogeneity of the nine domains of the
European Organization for Research and Treatment of Can-
cer Quality of Life Questionnaire (EORTC-QLQ-C30). All
domains except cognitive functioning turned out to be inter-
nally reliable, and a number of predictors of heterogeneity
were identified.
All authors who find the process of electronic submis-
sion of articles cumbersome and time consuming will ap-
preciate Buckley’s strong plea for another guideline in
addition to the many that have already been launched: a
guideline on standard formatting for articles being submit-
ted for peer review. Reading his proposal, as editors, we are
happy to say that the Journal of Clinical Epidemiology is
moving toward a procedure in which specific detailed for-
mat requirements will only be needed to comply with after
acceptance for publication.
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